131 related articles for article (PubMed ID: 9914785)
1. CD44H participates in the intrahepatic growth of murine colon 26 adenocarcinoma cells.
Ogoshi T; Ishii S; Mizoi T; Harada N; Sato W; Saito K; Ogawa H; Inabe K; Shiiba K; Matsuno S
Jpn J Cancer Res; 1998 Nov; 89(11):1160-8. PubMed ID: 9914785
[TBL] [Abstract][Full Text] [Related]
2. Expression of variant CD44-messenger RNA in colorectal adenocarcinomas and adenomatous polyps in humans.
Imazeki F; Yokosuka O; Yamaguchi T; Ohto M; Isono K; Omata M
Gastroenterology; 1996 Feb; 110(2):362-8. PubMed ID: 8566581
[TBL] [Abstract][Full Text] [Related]
3. Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells.
Harada N; Mizoi T; Kinouchi M; Hoshi K; Ishii S; Shiiba K; Sasaki I; Matsuno S
Int J Cancer; 2001 Jan; 91(1):67-75. PubMed ID: 11149422
[TBL] [Abstract][Full Text] [Related]
4. Restoration of CD44H expression in colon carcinomas reduces tumorigenicity.
Tanabe KK; Stamenkovic I; Cutler M; Takahashi K
Ann Surg; 1995 Oct; 222(4):493-501; discussion 501-3. PubMed ID: 7574929
[TBL] [Abstract][Full Text] [Related]
5. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
[TBL] [Abstract][Full Text] [Related]
6. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.
Liao HX; Levesque MC; Patton K; Bergamo B; Jones D; Moody MA; Telen MJ; Haynes BF
J Immunol; 1993 Dec; 151(11):6490-9. PubMed ID: 7504022
[TBL] [Abstract][Full Text] [Related]
7. Expression and function of the CD44 glycoprotein in melanoma cell lines.
East JA; Mitchell SD; Hart IR
Melanoma Res; 1993 Oct; 3(5):341-6. PubMed ID: 7507366
[TBL] [Abstract][Full Text] [Related]
8. Involvement of adhesion molecules in metastasis of SW1990, human pancreatic cancer cells.
Hosono J; Narita T; Kimura N; Sato M; Nakashio T; Kasai Y; Nonami T; Nakao A; Takagi H; Kannagi R
J Surg Oncol; 1998 Feb; 67(2):77-84. PubMed ID: 9486777
[TBL] [Abstract][Full Text] [Related]
9. CpG ODN, Toll like receptor (TLR)-9 agonist, inhibits metastatic colon adenocarcinoma in a murine hepatic tumor model.
Kim IY; Yan X; Tohme S; Ahmed A; Cordon-Cardo C; Shantha Kumara HM; Kim SK; Whelan RL
J Surg Res; 2012 May; 174(2):284-90. PubMed ID: 21324492
[TBL] [Abstract][Full Text] [Related]
10. The role of CD44H molecule in the interactions between human monocytes and pancreatic adenocarcinoma-derived microvesicles.
Baj-Krzyworzeka M; Weglarczyk K; Szatanek R; Mytar B; Baran J; Siedlar M
Folia Histochem Cytobiol; 2019; 57(1):28-34. PubMed ID: 30957871
[TBL] [Abstract][Full Text] [Related]
11. Expression of two isoforms of CD44 in human endometrium.
Behzad F; Seif MW; Campbell S; Aplin JD
Biol Reprod; 1994 Oct; 51(4):739-47. PubMed ID: 7529574
[TBL] [Abstract][Full Text] [Related]
12. Ratio of CD44 epithelial variant to CD44 hematopoietic variant is a useful prognostic indicator in gastric and colorectal carcinoma.
Shibuya Y; Okabayashi T; Oda K; Tanaka N
Jpn J Clin Oncol; 1998 Oct; 28(10):609-14. PubMed ID: 9839501
[TBL] [Abstract][Full Text] [Related]
13. CD44 hyaluronate binding influences growth kinetics and tumorigenicity of human colon carcinomas.
Takahashi K; Stamenkovic I; Cutler M; Saya H; Tanabe KK
Oncogene; 1995 Dec; 11(11):2223-32. PubMed ID: 8570172
[TBL] [Abstract][Full Text] [Related]
14. Functional heterogeneity of CD44 molecules in ovarian cancer cell lines.
Cannistra SA; DeFranzo B; Niloff J; Ottensmeir C
Clin Cancer Res; 1995 Mar; 1(3):333-42. PubMed ID: 9815989
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
Wai PY; Mi Z; Guo H; Sarraf-Yazdi S; Gao C; Wei J; Marroquin CE; Clary B; Kuo PC
Carcinogenesis; 2005 Apr; 26(4):741-51. PubMed ID: 15661802
[TBL] [Abstract][Full Text] [Related]
16. Engagement of variant CD44 confers resistance to anti-integrin antibody-mediated apoptosis in a colon carcinoma cell line.
Bates RC; Elith CA; Thorne RF; Burns GF
Cell Adhes Commun; 1998 Jun; 6(1):21-38. PubMed ID: 9759519
[TBL] [Abstract][Full Text] [Related]
17. The association of metastasis with the expression of adhesion molecules in cell lines derived from human gastric cancer.
Nakashio T; Narita T; Sato M; Akiyama S; Kasai Y; Fujiwara M; Ito K; Takagi H; Kannagi R
Anticancer Res; 1997; 17(1A):293-9. PubMed ID: 9066667
[TBL] [Abstract][Full Text] [Related]
18. Relationship between CD44 expression and differentiation of human prostate adenocarcinomas.
Takahashi S; Kimoto N; Orita S; Cui L; Sakakibara M; Shirai T
Cancer Lett; 1998 Jul; 129(1):97-102. PubMed ID: 9714340
[TBL] [Abstract][Full Text] [Related]
19. DNA vaccination with CD44 variant isoform reduces mammary tumor local growth and lung metastasis.
Wallach-Dayan SB; Rubinstein AM; Hand C; Breuer R; Naor D
Mol Cancer Ther; 2008 Jun; 7(6):1615-23. PubMed ID: 18566232
[TBL] [Abstract][Full Text] [Related]
20. [Expression of CD44 variant isoforms in human primary colon carcinomas and metastasis].
Shibuya Y; Okabayashi T; Oda K; Tanaka N; Orita K
Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():169-73. PubMed ID: 8678563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
